Evidence for inflammatory signaling in idiopathic pulmonary artery hypertension: TRPC6 and nuclear factor-κB

Circulation

Volumn 119, Issue 17, 2009, Pages 2297-2298

  Hamid, Rizwan ^a   Newman, John H ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; CALCIUM ION; HYALURONAN SYNTHASE 1; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; SEROTONIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UNCLASSIFIED DRUG; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRPC6 PROTEIN, HUMAN;

BMPR2 GENE; BYPASS SURGERY; DNA POLYMORPHISM; EDITORIAL; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; IDIOPATHIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; STRESS; TEMPERATURE SENSITIVITY; ACTIVE TRANSPORT; GENETICS; HYPERTENSION; INFLAMMATION; METABOLISM; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ACTIVE TRANSPORT, CELL NUCLEUS; HUMANS; HYPERTENSION; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PULMONARY ARTERY; SIGNAL TRANSDUCTION; TRPC CATION CHANNELS; UP-REGULATION;

EID: 66349110029     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.855197     Document Type: Editorial

References (23)

1. Newman JH, Fanburg BL, Archer SL, Badesch DB, Barst RJ, Garcia JG, Kao PN, Knowles JA, Loyd JE, McGoon MD, Morse JH, Nichols WC, Rabinovitch M, Rodman DM, Stevens T, Tuder RM, Voelkel NF, Gail DB. Pulmonary arterial hypertension: future directions: report of a National Heart, Lung, and Blood Institute/Office of Rare Diseases workshop. Circulation. s2004;109:2947-2952.
2. Morrell NW. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? Proc Am Thorac Soc. 2006;3:680-686.
3. Raiesdana A, Loscalzo J. Pulmonary arterial hypertension. Ann Med. 2006;38:95-110.
4. Eddahibi S, Guignabert C, Barlier-Mur AM, Dewachter L, Fadel E, Dartevelle P, Humbert M, Simonneau G, Hanoun N, Saurini F, Hamon M, Adnot S. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation. 2006;113:1857-1864.
5. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest. 2001;108: 1141-1150.
6. Sullivan CC, Du L, Chu D, Cho AJ, Kido M, Wolf PL, Jamieson SW, Thistlethwaite PA. Induction of pulmonary hypertension by an angio-poietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci U S A. 2003;100: 12331-12336.
7. Richter A, Yeager ME, Zaiman A, Cool CD, Voelkel NF, Tuder RM. Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2004;170: 1340-1348.
8. Harrison RE, Berger R, Haworth SG, Tulloh R, Mache CJ, Morrell NW, Aldred MA, Trembath RC. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood. Circulation. 2005;111:435-441.
9. Shintani M, Yagi H, Nakayama T, Saji T, Matsuoka R. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. J Med Genet. February 26, 2009. DOI: 10.1136/jmg.2008.062703. Available at: http://jmg.bmj.com/cgi/content/short/jmg.2008.062703v271=2jmg-ahead-tab. Accessed April 16, 2009.
10. Papakonstantinou E, Kouri FM, Karakiulakis G, Klagas I, Eickelberg O. Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension. Eur Respir J. 2008;32:1504-1512.
11. Laumanns IP, Fink L, Wilhelm J, Wolff JC, Mitnacht-Kraus R, Graef-Hoechst S, Stein MM, Bohle RM, Klepetko W, Hoda MA, Schermuly RT, Grimminger F, Seeger W, Voswinckel R. The non-canonical WNT-pathway is operative in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol. November 21, 2008. DOI: 10.1165/rcmb.2008-0153OC. Available at: http://ajrcmb.atsjournals. org. Accessed April 16, 2009.
12. Kunichika N, Yu Y, Remillard CV, Platoshyn O, Zhang S, Yuan JXJ. Overexpression of TRPC1 enhances pulmonary vasoconstriction induced by capacitative Ca2+ entry. Am J Physiol Lung Cell Mol Physiol. 2004;287:L962-L969.
13. Kunichika N, Landsberg JW, Yu Y, Kunichika H, Thistlethwaite PA, Rubin LJ, Yuan JXJ. Bosentan inhibits transient receptor potential channel expression in pulmonary vascular myocytes. Am J Respir Crit Care Med. 2004;170:1101-1107.
14. Dietrich A, Kalwa H, Fuchs B, Grimminger F, Weissmann N, Gudermann T. In vivo TRPC functions in the cardiopulmonary vasculature. Cell Calcium. 2007;42:233-244.
15. Watanabe H, Murakami M, Ohba T, Takahashi Y, Ito H. TRP channel and cardiovascular disease. Pharmacol Ther. 2008;118:337-351.
16. Yu Y, Keller ST, Remillard CV, Safrina O, Nicholson A, Zhang SL, Jiang W, Vangala N, Landsberg JW, Wang JY, Thistlethwaite PA, Channick RN, Robbins IM, Loyd JE, Ghofrani HA, Grimminger F, Schermuly RT, Cahalan MD, Rubin LJ, Yuan JXJ. A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation. 2009;119:2313-2322.
17. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, Yuan JX. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol. 2003;284:C316-C330.
18. Perkett EA, Pelton RW, Meyrick B, Gold LI, Miller DA. Expression of transforming growth factor-beta mRNAs and proteins in pulmonary vascular remodeling in the sheep air embolization model of pulmonary hypertension. Am J Respir Cell Mol Biol. 1994;11:16-24.
19. Sata M. Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. Arterioscler Thromb Vasc Biol. 2006;26:1008-1014.
20. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-228.
21. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol. 2008;8:837-848.
22. Sawada H, Mitani Y, Maruyama J, Jiang BH, Ikeyama Y, Dida FA, Yamamoto H, Imanaka-Yoshida K, Shimpo H, Mizoguchi A, Maruyama K, Komada Y. A nuclear factor-kappaB inhibitor pyrrolidine dithiocar-bamate ameliorates pulmonary hypertension in rats. Chest. 2007;132: 1265-1274.
23. Boyle EM Jr, Morgan EN, Kovacich JC, Canty TG Jr, Verrier ED. Microvascular responses to cardiopulmonary bypass. J Cardiothorac and Vasc Anesth. 1999;13(4 Suppl 1):30-35;discussion 36-37.